ABSTRACT
A follow-up study from 2005 to 2010 was carried out in two herds where eradication programme for the bovine herpes virus-1 (BoHV-1) infection depends on the vaccination with inactivated glycoprotein E-deleted vaccine that was started in 2001 following the vaccination with inactivated conventional vaccine between 1999 and 2001. For serological screening, a total of 12,976 sera sampled over several sampling times approximately 6 months of interval during 5 years (2005-2010) were tested for glycoprotein E (gE)- and glycoprotein B-specific antibodies using ELISA. According to the serological evidence, the long-term persistence of BoHV-1 antibodies, success of marker vaccine, first vaccination time of the calves in herds regularly vaccinated, etc. were discussed in this paper. In conclusion, the vaccination programme using gE (-) marker vaccines, with making efforts to prevent the other factors about transmission of infection, was suggested for the eradication of BoHV-1 infection in Turkey as many EU countries. This is the first report on the BoHV-1 eradication programme in some dairy cattle in Turkey.
Subject(s)
Herpesvirus 1, Bovine/immunology , Infectious Bovine Rhinotracheitis/prevention & control , Viral Proteins/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Cattle , Cattle Diseases/prevention & control , Dairying , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Herpesviridae Infections/prevention & control , Herpesviridae Infections/veterinary , Infectious Bovine Rhinotracheitis/virology , Longitudinal Studies , Pilot Projects , Turkey , Vaccination , Vaccines, Inactivated , Vaccines, Marker/immunologyABSTRACT
The present study investigated the seroprevalance of Visna Maedi Virus (VMV) and Border Disease Virus (BDV) infections in sheeps in regions in and around Van province, Turkey. Sample materials were taken from 360 sheep sent to slaughterhouses around Van. All serum samples were examined using ELISA for antibodies for Visna Maedi (VMV) and Border Disease (BDV) viruses. Of these, 38 (10.5%) tested positive for Visna Maedi virus antibodies and 163 (45.2%) for Border Disease virus antibodies. Varying numbers of samples were positive for both virus antibodies across the towns of Ercis, Çaldiran, Erçek and Baskale in Van, Agri and Hakkari provinces. Both infections should be eliminated by informing veterinarians and animal owners, identifying and eliminating persistently infected animals from flocks, and conducting appropriate eradication measures. Economic support should be provided for this.(AU)
O presente estudo investigou a seroprevalência de infecções por Visna Maedi Virus (VMV) e Border Disease Virus (BDV) em ovelhas nas redondezas da província de Van, na Turquia. Amostras foram retiradas de 360 ovelhas enviadas a um matadouro próximo de Van. Todas as amostras foram examinadas usando ELISA para anticorpos de visna Maedi (VMW) e Border Disease (BDV). Destes, 38 (10.5%) foram positivos para anticorpos virais de Visna Maedi e 163 (45.2%) para anticorpos virais de Border Disease. Números variados de amostras foram positivos para ambos os anticorpos nos municípios de Ercis, Çaldiran, Erçek e Baskale, nas províncias Van, Agri e Hakkari. Ambas as infecções devem ser eliminadas informando veterinários e proprietários, identificando e eliminando animais persistentemente infectados de rebanhos, e conduzindo medidas apropriadas de erradicação. Suporte financeiro deve ser providenciado para tal.(AU)
Subject(s)
Border disease virus/pathogenicity , Seroepidemiologic Studies , Visna-maedi virus/pathogenicity , Enzyme-Linked Immunosorbent Assay/statistics & numerical dataABSTRACT
The equid herpesvirus 2 (EHV-2) and 5 (EHV-5), identified agents of respiratory infections and keratoconjunctivitis cases in some equids, comprise a high degree of antigenic heterogeneity. Prevalence and genetic characterization of EHV-2 and EHV-5 strains from Turkey were investigated in this study. A total of 73 nasal swabs and 54 blood specimens were sampled from horses with respiratory tract diseases characterized by mucopurulent nasal discharge and occasional coughing. Overall, EHV-2- and EHV-5-specific DNA amplicons were obtained from 19.2% (14/73) and 21.9% (16/73) of horses tested by multiplex nested PCR. Sequences of EHV-2 and EHV-5 glycoprotein B (gB) gene were used in a phylogenetic analysis that included six EHV-2 and three EHV-5 isolates, which showed that the Turkish EHV-2 and EHV-5 strains have marked sequence divergence from European strains and from each other. Turkish EHV-2 isolates were divided into two distinct subdivisions, and a few isolates were located on a separate branch. This study provides the first epidemiological and phylogenetical report about EHV-2 and EHV-5 infections in Turkey.
